DeutschNewstral
Article
bizjournals.com on 2015-05-05 22:56
Teva takes its case for buying Mylan to the company's stockholders
Related news
Teva buying Allergan, drops Mylan bidPhilly.com
Teva offers to buy Mylan for $40.1Bobserver-reporter.com- Teva buying up shares of Mylanbizjournals.com
- Report: Teva getting ready to up its offer for Mylanbizjournals.com
Teva offers to buy Mylan in $40B cash and stockThe Salt Lake Tribune
Teva offers to buy Mylan in $40 billion dealtimesofisrael.com- Teva brings in new adviser for proposed Mylan dealbizjournals.com
- Teva buying California CNS drug developer for $3.2Bbizjournals.com
Mylan rejects Teva Pharmaceutical's takeover bidpost-gazette.com
Mylan chief: Acquisition by Teva not feasibleHaaretz
Teva still targets Mylan despite rejectionThe Jerusalem Post (JPost.com)- The Teva vs. Mylan drug warThe Jerusalem Post (JPost.com)
- Teva drops bid for Mylan, buys Allergan's generic drug unitbizjournals.com
Teva offers to buy Mylan in $40.1B cash-and-stock dealneworleanscitybusiness.com- Teva drops bid for Mylan, buys Allergan's generic drug unit for $40.5 billionbizjournals.com
Former Teva chairman resigns from company's boardisraelnationalnews.com- Foundation provides new twist in Teva-Mylan sagabizjournals.com
- Teva brings in new advisor for proposed Mylan dealbizjournals.com
- Teva makes unsolicited $82-a-share offer for Mylanbizjournals.com
Israel’s Teva drops bid for Mylan, buys Allergan for $40.5Btriblive.com